Biofer SpA

Biofer SpA is an Italian pharmaceutical company headquartered in Medolla, Italy, founded in 1985. The company is an independent, globally oriented manufacturer of active pharmaceutical ingredients (APIs), with a portfolio that includes iron complexes used as antianemics, heparins and glycosaminoglycans as antithrombotics, steroids as anti-shock and antiallergic agents, folinates as antitumor adjuvants, and enzymes as anti-inflammatories. Biofer describes itself as "Italian by birth, global by vocation," combining decades of experience with qualified human resources to develop innovative products and processes. The company operates across the full spectrum of API development and production, from research and development through manufacturing and commercialization. Its core therapeutic categories are iron complexes, heparins, glycosaminoglycans, steroids, folinates and enzymes — the active ingredients at the heart of many modern medicines and innovative treatments. Biofer emphasizes quality and ethics as foundational values, and states that it develops its products in strict compliance with Good Manufacturing Practices (GMP). It holds all authorizations from AIFA (the Italian Medicines Agency) and the Italian Ministry of Health recognized throughout Europe, and undergoes regular inspections by its clients to ensure transparency and control. Biofer positions itself as an independent Italian company with a global reach, serving different types of customers with flexible solutions tailored to specific needs. Its expertise in the chemistry of various API categories, combined with continuous research and development, allows it to offer adaptable, scientifically advanced solutions. The company also emphasizes environmental responsibility and sustainability, holding certifications such as UNI EN ISO 14001. With approximately four decades of operation, Biofer has established itself as a recognized player in the API sector, maintaining a presence in the pharmaceutical supply chain by supplying active ingredients to pharmaceutical companies. Its mission centers on consolidating its industry presence through continuous innovation, excellence, and responsibility toward health and the environment.

Biofer SpA was founded in 1985 as an Italian pharmaceutical company. From its inception, the company focused entirely on the various stages of development and production of several major categories of active pharmaceutical ingredients (APIs), which it describes as the heart of modern medicine and the basis of most innovative and successful treatments. These categories include iron complexes, heparins, glycosaminoglycans, steroids, folinates and enzymes. Over the decades, Biofer has built deep expertise in the chemistry of these API families and has maintained a constant commitment to research and development. This has allowed the company to offer flexible solutions to meet the specific needs of different types of customers. The company describes itself as "Italian by birth, global by vocation," reflecting its roots in Italy and its international commercial reach. Biofer operates as an independent company, a status it has maintained for approximately forty years. It develops its products in strict compliance with Good Manufacturing Practices (GMP) and holds all authorizations from AIFA (the Italian Medicines Agency) and the Italian Ministry of Health recognized throughout Europe. To ensure maximum transparency and control, the company regularly receives visits and inspections from its clients. Environmental attention and sustainability are also part of Biofer's operations, as demonstrated by certifications such as UNI EN ISO 14001. The company continues to position itself at the forefront of innovation in pharmaceutical active ingredients, aiming to contribute to a healthier world through science and quality.

• 1985

  Biofer SpA founded in Italy as a pharmaceutical company focused on active pharmaceutical ingredients.

• Company maintains independent status for approximately forty years.

• Obtains UNI EN ISO 14001 certification for environmental management.

Independent Italian API manufacturer with a global vocation, combining quality, ethics, innovation and environmental responsibility.

• Iron complexes as antianemics

  Iron-based active pharmaceutical ingredients used in the treatment of anemia.

• Iron sucrose injection

  An injectable iron preparation.

• Heparins and glycosaminoglycans as antithrombotics

  Active ingredients used to prevent blood clot formation.

• Steroids as anti-shock and antiallergic agents

  Steroid APIs for emergency and allergic conditions.

• Foliates as antitumor adjuvants

  Folate-based APIs used in support of cancer therapy.

• Enzymes as anti-inflammatories

  Enzyme-based APIs with anti-inflammatory applications.

1. 1Biofer - Iron Complexes as antianemics and Iron Sucrose Injectionbioferspa.com
2. 2Chi Siamo - Bioferbioferspa.com
3. 3Biofer SpA (Italy) - Wikidatawikidata.org